Skip to main content

Table 3 Characteristics of the retroperitoneal fibrosis patients with malignancies (n = 38)

From: Association of retroperitoneal fibrosis with malignancy and its outcomes

Case Sex Age at RPF diagnosis Age at malignancy diagnosis Malignancy site Malignancy type Stage (TNM)
1 M 68 68 Lung Adenocarcinoma I
2 M 76 76 Lung NSCLC IV
3 M 52 52 Stomach Adenocarcinoma IV
4 M 67 67 Stomach Adenocarcinoma IV
5 F 82 82 Stomach Adenocarcinoma
6 M 68 67 Small intestine GIST IV
7 M 49 49 Colon Adenocarcinoma IIA
8 M 52 51 Colon Adenocarcinoma IIIB,
9 M 54 54 Pancreas Adenocarcinoma
10 M 78 78 Pancreas Adenocarcinoma
11 M 47 46 Kidney Clear cell II
12 M 64 64 Kidney Clear cell I
13 M 51 51 Renal pelvis TCC IV
14* F 79 79 Renal pelvis TCC III
15 F 77 78 Renal pelvis TCC IV
16 F 75 75 GB Adenocarcinoma
17 M 67 67 Bladder TCC I
18† F 67 67 Bone Adenocarcinoma IV
19 M 74 74 Prostate Adenocarcinoma II
20 M 73 73 Peritoneum MM III
21 F 64 64 Peritoneum NHL III
22 F 75 75 Lymph node Squamous IV
23 F 50 49 Thyroid PTC I
24‡ M 67 69 Lung Adenocarcinoma I
25 M 53 51 Stomach Signet ring I
26 M 68 67 Colon Adenocarcinoma IIIB
27§ M 78 80 Rectum Adenocarcinoma
28 M 40 43 Peritoneum Liposarcoma IIIB
29 F 42 39 Cervix uteri Adeno II
30 M 49 52 BM MDS
31‡ M 67 71 BM MM
32† F 67 62 Breast Adenocarcinoma II
33 F 66 72 Thyroid PTC II
34¶ M 71 63 Larynx Squamous IV
35¶ M 71 60 Lung Squamous I
36 M 65 82 Stomach Adenocarcinoma I
37§ M 78 71 Stomach Adenocarcinoma I
38 F 64 45 Skin Basal cell I
  1. RPF retroperitoneal fibrosis; NSCLC non-small cell lung cancer; GIST gastrointestinal stromal tumor; TCC transitional cell carcinoma; GB gall bladder; BM bone marrow; NHL non-Hodgkin lymphoma; PTC papillary thyroid cancer; MDS myelodysplastic syndrome; MM multiple myeloma. *,†RPF newly developed while the cancer worsened and spread. †,‡,§,¶Those cases were the same patient. RPF and cancer were diagnosed within a 1-year interval in 22 cases (case numbers 1–22) and a greater than 5-year interval in 7 cases (case numbers 32–38)